Related Experiment Video
Updated: Jun 26, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Genetic identification of intestinal microsporidia species in immunocompromised patients in Tunisia
Najla Chabchoub1, Rim Abdelmalek, Fethi Mellouli
1Laboratoire de Recherche 05-SP-03, Laboratoire de Parasitologie, Institut Pasteur de Tunis, Tunis, Tunisia.
Abstract:
Stool samples from 86 immunocompromised patients (51 human immunodeficiency virus (HIV)-infected patients and 35 patients with haematologic malignancies) were systematically screened for intestinal microspordiosis by microscopic examination and polymerase chain reaction (PCR) using universal primer V1/PMP2. Nine samples (10.5%) showed amplification with the predictive size of fragment (6 from HIV-infected patients and 3 from patients with myeloma). Only 5 out of them (all HIV-infected patients) were revealed positive by microscopy. By means of amplicons fragment size, species-specific primers (V1/EB450, V1/IS500) and sequencing, 3 microsporidia species were for the first time identified in Tunisia: Enterocytozoon bieneusi (3 isolates), Encephelitozoon intestinalis (2 isolates), and Encephalitozoon hellem (1 isolate). Systematic use of such sensitive and discriminative molecular tools will contribute to determining the true prevalence of microsporidiosis in Tunisia and to better management of infected immunocompromised subjects.
Insights
Molecular tools detected three microsporidia species in immunocompromised patients in Tunisia. This study highlights the need for sensitive diagnostics to manage intestinal microsporidiosis in vulnerable populations.
Area of Science:
- Medical Parasitology
- Molecular Diagnostics
- Infectious Diseases
Background:
- Intestinal microsporidiosis is an opportunistic infection common in immunocompromised individuals.
- Diagnosis can be challenging with conventional microscopy, necessitating advanced molecular techniques.
- Limited data exists on microsporidiosis prevalence in Tunisia, particularly in specific patient groups.
Purpose of the Study:
- To systematically screen immunocompromised patients for intestinal microsporidiosis using microscopy and PCR.
- To identify the specific microsporidia species present in the Tunisian patient cohort.
- To evaluate the utility of molecular tools for diagnosing microsporidiosis in this population.
Main Methods:
- Stool samples from 86 immunocompromised patients (HIV-infected and hematologic malignancy patients) were analyzed.
- Microscopic examination and polymerase chain reaction (PCR) with universal primers were employed.
- Species-specific primers and sequencing were used for definitive identification of microsporidia.
Main Results:
- Nine samples (10.5%) tested positive by PCR, with six from HIV-infected patients and three from patients with myeloma.
- Microscopy confirmed five cases, all in HIV-infected patients.
- Three microsporidia species were identified for the first time in Tunisia: Enterocytozoon bieneusi, Encephalitozoon intestinalis, and Encephalitozoon hellem.
Conclusions:
- PCR is a more sensitive diagnostic tool for intestinal microsporidiosis than microscopy in immunocompromised patients.
- The identification of multiple microsporidia species underscores the importance of molecular diagnostics in Tunisia.
- Wider implementation of these molecular tools can improve the diagnosis and management of microsporidiosis in immunocompromised individuals.
Related Concept Videos
Fungal Phylum Microsporidia
Rapid Identification of Pathogens
Automated Microbial Diagnostics
